MindWalk Holdings Corp. (HYFT)
1.34
+0.01
(+0.75%)
USD |
NASDAQ |
Oct 02, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
MindWalk Holdings Gross Profit Margin (Quarterly) : 58.58% for July 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 58.58% |
| April 30, 2026 | 60.63% |
| January 31, 2026 | 59.26% |
| October 31, 2025 | 64.55% |
| July 31, 2025 | 48.31% |
| April 30, 2025 | 57.95% |
| January 31, 2025 | 45.49% |
| October 31, 2024 | 32.17% |
| July 31, 2024 | 20.54% |
| April 30, 2024 | 37.27% |
| January 31, 2024 | 39.99% |
| October 31, 2023 | 36.47% |
| July 31, 2023 | 34.25% |
| April 30, 2023 | 36.01% |
| January 31, 2023 | 37.34% |
| October 31, 2022 | 35.22% |
| July 31, 2022 | -41.29% |
| April 30, 2022 | -1.62% |
| January 31, 2022 | -6.92% |
| October 31, 2021 | -2.65% |
| Date | Value |
|---|---|
| July 31, 2021 | -16.41% |
| April 30, 2021 | -17.07% |
| January 31, 2021 | 20.03% |
| October 31, 2020 | 0.51% |
| July 31, 2020 | 2.32% |
| April 30, 2020 | -17.73% |
| January 31, 2020 | 6.86% |
| October 31, 2019 | 57.75% |
| July 31, 2019 | 30.50% |
| April 30, 2019 | -29.64% |
| January 31, 2019 | 53.07% |
| October 31, 2018 | 3.65% |
| July 31, 2018 | 3.73% |
| April 30, 2018 | -22.44% |
| January 31, 2018 | -8.17% |
| October 31, 2017 | -19.26% |
| July 31, 2017 | -48.30% |
| April 30, 2017 | 62.85% |
| January 31, 2017 | 15.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Repligen Corp. | 49.25% |
| Bio-Techne Corp. | 65.22% |
| BioLife Solutions, Inc. | 63.69% |
| Maravai Lifesciences Holdings, Inc. | 40.14% |
| MaxCyte, Inc. | 63.86% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -118.2% |
| Return on Assets | -66.20% |
| Return on Invested Capital | -94.66% |
| Profit Margin (Quarterly) | -158.7% |
| Operating Margin (Quarterly) | -159.9% |
| Return on Net Operating Assets | -199.3% |